Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Anamorelin on Cancer-Related-Fatigue in Patients With Advanced Cancer

NCT03035409 is registered in ClinicalTrials.gov with M.D. Anderson Cancer Center as lead sponsor.

NCT NCT03035409
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03035409 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Anamorelin on Cancer-Related-Fatigue in Patients With Advanced Cancer
Lead sponsor
M.D. Anderson Cancer Center
Phase
Phase 2
Overall status
Active, not recruiting
Start date
February 8, 2017
Completion date
February 28, 2028
Enrollment
129 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced malignant solid neoplasm, c-reactive protein measurement, cancer fatigue, metastatic malignant solid neoplasm, recurrent malignant solid neoplasm, weight loss